AAAAAA

   
Results: 1-18 |
Results: 18
EPIRUBICIN (EPI) AND VINORELBINE (VNR) - HIGH-ACTIVITY, DOSE DENSE REGIMEN FOR PRIMARY BREAST-CANCER
Authors: NISTICO G DEMATTEIS A VALENZA R QUATTROCCHIO D FARRIS A VACCARO A CREMONESI M DOTTAVIO AM GARUFI C ROSSI E AGOSTARA B GALLA DAP LAZZARO B BORZACCHINI AM TERZOLI E
Citation: G. Nistico et al., EPIRUBICIN (EPI) AND VINORELBINE (VNR) - HIGH-ACTIVITY, DOSE DENSE REGIMEN FOR PRIMARY BREAST-CANCER, European journal of cancer, 34, 1998, pp. 38-38
EPIRUBICIN (EPI) AND VINORELBINE (VNR) - HIGH-ACTIVITY, DOSE-DENSE REGIMEN FOR PRIMARY BREAST-CANCER
Authors: NISTICO C DEMATTEIS A VALENZA R QUATTROCCHIO D FARRIS A VACCARO A CREMONESI M DOTTAVIO AM MILELLA M GARUFI C ROSSI E AGOSTARA B GALLA DAP LAZZARO B BORZACCHINI AM TERZOLI E
Citation: C. Nistico et al., EPIRUBICIN (EPI) AND VINORELBINE (VNR) - HIGH-ACTIVITY, DOSE-DENSE REGIMEN FOR PRIMARY BREAST-CANCER, Annals of oncology, 9, 1998, pp. 118-118
GEMCITABINE PLUS VINORELBINE (GEMVIN) IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - SEQUENTIAL PHASE-I AND PHASE-II TRIALS
Authors: CIGOLARI S GRIDELLI C FRONTINI L GULISANO M ROBBIATI SF FARRIS A CLERICI M CASTIGLIONE F PIAZZA E IANNIELLO GP PERRONE F
Citation: S. Cigolari et al., GEMCITABINE PLUS VINORELBINE (GEMVIN) IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - SEQUENTIAL PHASE-I AND PHASE-II TRIALS, Annals of oncology, 9, 1998, pp. 419-419
CISPLATIN, EPIRUBICIN, AND LONIDAMINE COMBINATION REGIMEN AS FIRST-LINE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER - A PILOT-STUDY
Authors: DOGLIOTTI L DANESE S BERRUTI A ZOLA P BUNIVA T BOTTINI A RICHIARDI G MORO G FARRIS A BAU MG PORCILE G
Citation: L. Dogliotti et al., CISPLATIN, EPIRUBICIN, AND LONIDAMINE COMBINATION REGIMEN AS FIRST-LINE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER - A PILOT-STUDY, Cancer chemotherapy and pharmacology, 41(4), 1998, pp. 333-338
A MULTICENTER, DOUBLE-BLIND, RANDOMIZED TRIAL COMPARING ONDANSETRON VERSUS ONDANSETRON PLUS DEXAMETHASONE IN THE PROPHYLAXIS OF CISPLATIN-INDUCED DELAYED EMESIS
Authors: GRIDELLI C IANNIELLO GP AMBROSINI G MUSTACCHI G PEDICINI T FARRIS A IACOBELLI S ROSSI G MORETTI G ANGELINI F DELENA M DICARLO A BONSIGNORI M SABBATINI R CATALANO G ROSSI A OLIVIERI A FINA P BIANCO AR
Citation: C. Gridelli et al., A MULTICENTER, DOUBLE-BLIND, RANDOMIZED TRIAL COMPARING ONDANSETRON VERSUS ONDANSETRON PLUS DEXAMETHASONE IN THE PROPHYLAXIS OF CISPLATIN-INDUCED DELAYED EMESIS, International journal of oncology, 10(2), 1997, pp. 395-400
CLINICAL EFFICACY AND ENDOCRINE ACTIVITY OF VOROZOLE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS - RESULTS OF A MULTICENTRIC PHASE-II STUDY
Authors: BOCCARDO F AMOROSO D IACOBELLI S IRTELLI L FARRIS A MUSTACCHI G MESITI M BREMA F PACINI P CORTESI E NARDINI P GUIDA G LANGENAEKEN C
Citation: F. Boccardo et al., CLINICAL EFFICACY AND ENDOCRINE ACTIVITY OF VOROZOLE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS - RESULTS OF A MULTICENTRIC PHASE-II STUDY, Annals of oncology, 8(8), 1997, pp. 745-750
LACK OF EFFECTIVENESS OF ADJUVANT ALTERNATING CHEMOTHERAPY IN NODE-POSITIVE, ESTROGEN-RECEPTOR-NEGATIVE PREMENOPAUSAL BREAST-CANCER PATIENTS - RESULTS OF A MULTICENTRIC ITALIAN STUDY
Authors: BOCCARDO F RUBAGOTTI A AMOROSO D PERROTTA A SISMONDI P FARRIS A MESITI M GALLO L PACINI P VILLA E AGOSTARA B GENTA F DESANCTIS C SCOTTO T SPADARO P BUCCARAN G CAPPELLINI M BOLOGNESI A ALDRIGHETTI D TRAINA A SCHIEPPATI G SASSI M MUSTACCHI G BENETTI GP BANDUCCI S GATTI C ROLFO F IACOBELLI S IRTELLI L
Citation: F. Boccardo et al., LACK OF EFFECTIVENESS OF ADJUVANT ALTERNATING CHEMOTHERAPY IN NODE-POSITIVE, ESTROGEN-RECEPTOR-NEGATIVE PREMENOPAUSAL BREAST-CANCER PATIENTS - RESULTS OF A MULTICENTRIC ITALIAN STUDY, Cancer investigation, 15(6), 1997, pp. 505-512
SATELLITE SYMPOSIUM - EMERGING CONCEPTS I N CLINICAL ONCOLOGY - DOSE INTENSITY AND MULTIDRUG-RESISTANCE ACIREALE, JUNE 17, 1996 - FOREWORD
Authors: FARRIS A
Citation: A. Farris, SATELLITE SYMPOSIUM - EMERGING CONCEPTS I N CLINICAL ONCOLOGY - DOSE INTENSITY AND MULTIDRUG-RESISTANCE ACIREALE, JUNE 17, 1996 - FOREWORD, Tumori, 83(5), 1997, pp. 1-1
PROGNOSTIC FACTORS IN METASTATIC BREAST-CANCER PATIENTS OBTAINING OBJECTIVE RESPONSE OR DISEASE STABILIZATION AFTER FIRST-LINE CHEMOTHERAPYWITH EPIRUBICIN - EVIDENCE FOR A POSITIVE EFFECT OF MAINTENANCE HORMONAL-THERAPY ON OVERALL SURVIVAL
Authors: BERRUTI A ZOLA P BUNIVA T BAU MG FARRIS A SAROBBA MG BOTTINI A TAMPELLINI M DURANDO A DESTEFANIS M MONZEGLIO C MORO G SUSSIO M PERRONI D DOGLIOTTI L
Citation: A. Berruti et al., PROGNOSTIC FACTORS IN METASTATIC BREAST-CANCER PATIENTS OBTAINING OBJECTIVE RESPONSE OR DISEASE STABILIZATION AFTER FIRST-LINE CHEMOTHERAPYWITH EPIRUBICIN - EVIDENCE FOR A POSITIVE EFFECT OF MAINTENANCE HORMONAL-THERAPY ON OVERALL SURVIVAL, Anticancer research, 17(4A), 1997, pp. 2763-2768
VINORELBINE, CISPLATIN, AND 5-FLUOROURACIL AS INITIAL TREATMENT FOR PREVIOUSLY UNTREATED, UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - RESULTS OF A PHASE-II MULTICENTER STUDY
Authors: GEBBIA V MANTOVANI G FARRIS A AGOSTARA B DESOGUS A CURRELI L MOSCHELLA F DIGREGORIO C BAJETTA E GEBBIA N
Citation: V. Gebbia et al., VINORELBINE, CISPLATIN, AND 5-FLUOROURACIL AS INITIAL TREATMENT FOR PREVIOUSLY UNTREATED, UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - RESULTS OF A PHASE-II MULTICENTER STUDY, Cancer, 79(7), 1997, pp. 1394-1400
RELATIONSHIP BETWEEN CA-15-3 SERUM LEVELS AND DISEASE EXTENT IN PREDICTING OVERALL SURVIVAL OF BREAST-CANCER PATIENTS WITH NEWLY-DIAGNOSED METASTATIC DISEASE
Authors: TAMPELLINI M BERRUTI A GERBINO A BUNIVA T TORTA M GORZEGNO G FAGGIUOLO R CANNONE R FARRIS A DESTEFANIS M MORO G DELTETTO F DOGLIOTTI L
Citation: M. Tampellini et al., RELATIONSHIP BETWEEN CA-15-3 SERUM LEVELS AND DISEASE EXTENT IN PREDICTING OVERALL SURVIVAL OF BREAST-CANCER PATIENTS WITH NEWLY-DIAGNOSED METASTATIC DISEASE, British Journal of Cancer, 75(5), 1997, pp. 698-702
LONIDAMINE SIGNIFICANTLY INCREASES THE ACTIVITY OF EPIRUBICIN IN PATIENTS WITH ADVANCED BREAST-CANCER - RESULTS FROM A MULTICENTER PROSPECTIVE RANDOMIZED TRIAL
Authors: DOGLIOTTI L BERRUTI A BUNIVA T ZOLA P BAU MG FARRIS A SAROBBA MG BOTTINI A ALQUATI P DELTETTO F GOSSO P MONZEGLIO C MORO G SUSSIO M PERRONI D
Citation: L. Dogliotti et al., LONIDAMINE SIGNIFICANTLY INCREASES THE ACTIVITY OF EPIRUBICIN IN PATIENTS WITH ADVANCED BREAST-CANCER - RESULTS FROM A MULTICENTER PROSPECTIVE RANDOMIZED TRIAL, Journal of clinical oncology, 14(4), 1996, pp. 1165-1172
TREATMENT OF RECURRENT AND OR METASTATIC SQUAMOUS-CELL HEAD AND NECK-CARCINOMA WITH A COMBINATION OF VINORELBINE, CISPLATIN, AND 5-FLUOROURACIL - A MULTICENTER PHASE-II TRIAL/
Authors: GEBBIA V MANTOVANI G AGOSTARA B CONTU A FARRIS A COLUCCI G COGNETTI F RESTIVO G SPECIALE R FERRERO B TESTA A CURRELI L CARDINALE A BAJETTA E GEBBIA N
Citation: V. Gebbia et al., TREATMENT OF RECURRENT AND OR METASTATIC SQUAMOUS-CELL HEAD AND NECK-CARCINOMA WITH A COMBINATION OF VINORELBINE, CISPLATIN, AND 5-FLUOROURACIL - A MULTICENTER PHASE-II TRIAL/, Annals of oncology, 6(10), 1995, pp. 987-991
MEGESTROL-ACETATE PLUS ALPHA-2A-INTERFERON AS 2ND LINE THERAPY FOR POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - RESULTS OF A MULTICENTRIC PHASE-II TRIAL
Authors: AMOROSO D BOCCARDO F BALESTRERO M MIGLIETTA L BREMA F CELLERINO R FARRIS A FOLCO U IACOBELLI S MESITI M
Citation: D. Amoroso et al., MEGESTROL-ACETATE PLUS ALPHA-2A-INTERFERON AS 2ND LINE THERAPY FOR POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - RESULTS OF A MULTICENTRIC PHASE-II TRIAL, Breast cancer research and treatment, 33(3), 1995, pp. 265-268
A RANDOMIZED COMPARISON OF HIGH-DOSE EPIRUBICIN VERSUS HIGH-DOSE EPIRUBICIN PLUS LONIDAMINE IN ADVANCED BREAST-CANCER PATIENTS - FIRST RESULTS FROM A COOPERATIVE GROUP-STUDY
Authors: DOGLIOTTI L BERRUTI A BUNIVA T ZOLA P BAU MG FARRIS A SAROBBA MG BOTTINI A ALQUATI P DELTETTO F GOSSO P MONZEGLIO C MORO G SUSSIO M PERRONI D
Citation: L. Dogliotti et al., A RANDOMIZED COMPARISON OF HIGH-DOSE EPIRUBICIN VERSUS HIGH-DOSE EPIRUBICIN PLUS LONIDAMINE IN ADVANCED BREAST-CANCER PATIENTS - FIRST RESULTS FROM A COOPERATIVE GROUP-STUDY, International journal of oncology, 4, 1994, pp. 747-752
TAMOXIFEN OR SURGERY PINS TAMOXIFEN AS PRIMARY-TREATMENT FOR ELDERLY PATIENTS WITH OPERABLE BREAST-CANCER - THE GRETA TRIAL
Authors: MUSTACCHI G MILANI S PLUCHINOTTA A DEMATTEIS A RUBAGOTTI A PERROTA A BOLOGNESI A BONI C CACIOPPO C CECCHERINI R FARRIS A GAMBROSIER P GARATTINI P MAIORINO L SANTORO A SCANNI A SCHIEPPATI G SISMONDI P TRAINA A TARQUINI A ZADRO A
Citation: G. Mustacchi et al., TAMOXIFEN OR SURGERY PINS TAMOXIFEN AS PRIMARY-TREATMENT FOR ELDERLY PATIENTS WITH OPERABLE BREAST-CANCER - THE GRETA TRIAL, Anticancer research, 14(5B), 1994, pp. 2197-2200
HIGH-DOSE FOLINIC ACID (FA) AND FLUOROURACIL (FU) PLUS OR MINUS THYMOSTIMULIN (TS) FOR TREATMENT OF METASTATIC COLORECTAL-CANCER - RESULTS OF A RANDOMIZED MULTICENTER CLINICAL-TRIAL
Authors: MUSTACCHI G PAVESI L MILANI S IAFFAIOLI V CARACO A COMELLA G CONTU A FARRIS A ATTADOPARINELLO G NARCISI M BREMA F BENI A BUMMA C
Citation: G. Mustacchi et al., HIGH-DOSE FOLINIC ACID (FA) AND FLUOROURACIL (FU) PLUS OR MINUS THYMOSTIMULIN (TS) FOR TREATMENT OF METASTATIC COLORECTAL-CANCER - RESULTS OF A RANDOMIZED MULTICENTER CLINICAL-TRIAL, Anticancer research, 14(2B), 1994, pp. 617-619
CISPLATIN-VP16 ALTERNATING WITH CYCLOPHOSPHAMIDE-EPIRUBICIN VERSUS CYCLOPHOSPHAMIDE-EPIRUBICIN-VINCRISTINE IN SMALL-CELL LUNG-CANCER
Authors: FARRIS A BISAIL M SAROBBA MG SANNA G SCOTTO T VALZELLI S INTINI C
Citation: A. Farris et al., CISPLATIN-VP16 ALTERNATING WITH CYCLOPHOSPHAMIDE-EPIRUBICIN VERSUS CYCLOPHOSPHAMIDE-EPIRUBICIN-VINCRISTINE IN SMALL-CELL LUNG-CANCER, Journal of chemotherapy, 5(5), 1993, pp. 344-347
Risultati: 1-18 |